Quick Order

S100A8/MRP-8 Rabbit PAb

    DatasheetReviewsRelated ProductsProtocols
    Human S100A8 Antibody Product Information
    Immunogen:Recombinant Human S100A8 protein (Catalog#11138-H07E)
    Clone ID:
    Ig Type:Rabbit IgG
    Concentration:
    Formulation:0.2 μm filtered solution in PBS with 5% trehalose
    Preparation:Produced in rabbits immunized with purified, recombinant Human S100A8 (rh S100A8; Catalog#11138-H07E; NP_002955.2; Leu 2-Glu 93). Total IgG was purified by Protein A affinity chromatography .
    Other S100A8 Antibody Products
    Reactivity: Human  
    Application: ELISA  IHC-P  
    • Slide 1
    • Slide 1
    • Slide 1
    11138-RP02-200
    11138-RP02-50
    11138-RP02-100
    200 µg 
    50 µg 
    100 µg 
    Add to Cart
    Reactivity: Human  
    Application: IHC-P  
    • Slide 1
    11138-R101-50
    11138-R101-100
    50 µg 
    100 µg 
    Add to Cart
    Reactivity: Mouse  
    Application: ELISA  IHC-P  
    • Slide 1
    50228-T24-200
    50228-T24-100
    50228-T24-50
    200 µg 
    100 µg 
    50 µg 
    Add to Cart
    Reactivity: Mouse  
    Application: ELISA  
      50228-RP01-400
      50228-RP01-200
      50228-RP01-100
       
      200 µg 
      100 µg 
      Add to Cart
      S100A8/MRP-8 Background

      S100A8 is a member of the S100 protein family containing 2EF-hand calcium-binding motifs. S100 proteins are involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. Altered expression of S100A8 protein is associated with various diseases and cancers. S100A8 may have an immunoregulatory role by contributing to the regulation of fetal-maternal interactions. It may play a protective role and its absence may allow infiltration by maternal cells, a process eventually manifesting as resorption. The heterodimeric S100 protein complex S100A8/A9 which has been shown to be involved in inflammatory and neoplastic disorders. The complex can induce cell proliferation, or apoptosis, inflammation, collagen synthesis, and cell migration. S100A8/A9 has emerged as important pro-inflammatory mediator in acute and chronic inflammation. More recently, increased S100A8 and S100A9 levels were also detected in various human cancers, presenting abundant expression in neoplastic tumor cells as well as infiltrating immune cells. On the one hand, S100A8/A9 is a powerful apoptotic agent produced by immune cells, making it a very fascinating tool in the battle against cancer. It spears the risk to induce auto-immune response and may serve as a lead compound for cancer-selective therapeutics. In contrast, S100A8/A9 expression in cancer cells has also been associated with tumor development, cancer invasion or metastasis. Altogether, its expression and potential cytokine-like function in inflammation and in cancer suggests that S100A8/A9 may play a key role in inflammation-associated cancer.

      Human S100A8/MRP-8 References
    • Passey RJ, et al. (1999) S100A8: emerging functions and regulation. J Leukoc Biol. 66(4): 549-56.
    • Gebhardt C, et al. (2006) S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol. 72(11): 1622-31.
    • Halayko AJ, et al. (2009) S100A8/A9: a mediator of severe asthma pathogenesis and morbidity? Can J Physiol Pharmacol. 87(10): 743-55.
    • Ghavami S, et al. (2009) S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol. 625(1-3): 73-83.
    • Ha YS, et al. (2010) mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer. Korean J Urol. 51(1): 15-20.
    • Product nameProduct name
      All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.
      Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"